ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Durvalumab With Stereotactic Body Radiation Therapy (SBRT) vs Placebo With SBRT in Early Stage Unresected Non-small Cell Lung Cancer (NSCLC) Patients/ Osimertinib Following SBRT in Patients With Early Stage Unresected NSCLC Harboring an EGFR Mutation

ClinicalTrials.gov ID: NCT03833154

Public ClinicalTrials.gov record NCT03833154. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 5:06 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab With Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients With Unresected Stage I/II, Lymph-node Negative Non-small Cell Lung Cancer (PACIFIC-4/RTOG-3515) Osimertinib Following SBRT, a Single Arm Cohort for Patients With Unresected Stage I/II, Lymph Node Negative NSCLC Harboring a Sensitizing EGFR Mutation

Study identification

NCT ID
NCT03833154
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
AstraZeneca
Industry
Enrollment
724 participants

Conditions and interventions

Interventions

  • (Osimertinib cohort, single-arm, open-label separate cohort) Drug
  • Durvalumab Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2019
Primary completion
Oct 30, 2028
Completion
Oct 30, 2028
Last update posted
Apr 22, 2026

2019 – 2028

United States locations

U.S. sites
80
U.S. states
35
U.S. cities
74
Facility City State ZIP Site status
Research Site Tuscaloosa Alabama 35401
Research Site Chandler Arizona 85224
Research Site Phoenix Arizona 85004
Research Site Tucson Arizona 85719
Research Site Duarte California 91010
Research Site Long Beach California 90806
Research Site Los Angeles California 90095
Research Site San Diego California 92123
Research Site Newark Delaware 10709
Research Site Washington D.C. District of Columbia 20010
Research Site Bay Pines Florida 33744
Research Site Jacksonville Florida 32256
Research Site Miami Beach Florida 33140
Research Site Orlando Florida 32804
Research Site Atlanta Georgia 30322
Research Site Atlanta Georgia 30342
Research Site Chicago Illinois 60611
Research Site Chicago Illinois 60612
Research Site Chicago Illinois 60637
Research Site Decatur Illinois 62526
Research Site Elmhurst Illinois 60126
Research Site Naperville Illinois 60540
Research Site Fort Wayne Indiana 46845
Research Site Cedar Rapids Iowa 52403
Research Site Iowa City Iowa 52242
Research Site Elizabethtown Kentucky 42701
Research Site Lexington Kentucky 40503
Research Site Louisville Kentucky 40202
Research Site Metairie Louisiana 70006
Research Site New Orleans Louisiana 70121
Research Site South Portland Maine 04106
Research Site Annapolis Maryland 21401
Research Site Baltimore Maryland 21201
Research Site Rosedale Maryland 21237
Research Site Silver Spring Maryland 20910
Research Site Towson Maryland 21204
Research Site Boston Massachusetts 02215
Research Site Ann Arbor Michigan 48197
Research Site Detroit Michigan 48201
Research Site Royal Oak Michigan 48073
Research Site Duluth Minnesota 55805
Research Site Rochester Minnesota 55905
Research Site St Louis Missouri 63110
Research Site Omaha Nebraska 68105
Research Site Las Vegas Nevada 89135
Research Site Lebanon New Hampshire 03756
Research Site Camden New Jersey 08103
Research Site Paramus New Jersey 07652
Research Site Albany New York 12206
Research Site East Syracuse New York 13057
Research Site New Hyde Park New York 11042
Research Site New York New York 10016
Research Site Rochester New York 14642
Research Site Stony Brook New York 11794
Research Site Syracuse New York 13210
Research Site The Bronx New York 10461
Research Site The Bronx New York 10467
Research Site Winston-Salem North Carolina 27157
Research Site Grand Forks North Dakota 58201
Research Site Akron Ohio 44304
Research Site Cincinnati Ohio 45219
Research Site Cincinnati Ohio 45226
Research Site Cleveland Ohio 44106
Research Site Portland Oregon 97210
Research Site Portland Oregon 97213
Research Site Philadelphia Pennsylvania 19107
Research Site Pittsburgh Pennsylvania 15212
Research Site Charleston South Carolina 29425
Research Site Sioux Falls South Dakota 57105
Research Site Watertown South Dakota 57201
Research Site Austin Texas 78745
Research Site Dallas Texas 75235
Research Site Houston Texas 77030
Research Site Sherman Texas 75090
Research Site Burlington Vermont 05401
Research Site Richmond Virginia 23249
Research Site Bellingham Washington 98225
Research Site Seattle Washington 98195
Research Site Spokane Valley Washington 99216
Research Site Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03833154, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2026 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03833154 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →